FDA Holds Off Approval of New Merck Drug
As expected, the FDA is holding off on Merck’s new COX-2, Arcoxia. I’ve been bombarded with ads saying it’s “coming soon”. I guess not.
ADVERTISEMENT
More in Uncategorized
Past Week
-
Your doctor saved your life but won’t return your call [PODCAST]
-
Why bipolar II is not just a milder version of bipolar I
-
Opt-out states and physician-led anesthesia care explained
-
Why neurodivergent friendship is challenging but possible
-
Caring for the caregivers builds dementia-friendly cities
-
Medical expert witness report language gets cases struck
-
Past 6 Months
-
I Googled my own name and a corporate clinic I’ve never worked at appeared [PODCAST]
-
Rethinking the role of family physicians vs. specialists
-
How corporate health care ruined the medical profession
-
Clinicians are failing at value-based care because no one taught them the system [PODCAST]
-
A humorous parody of medical specialties and the modern patient
-
When shared decision making gives way to medical paternalism
-
Recent Posts
-
Dehumanization in medicine: the language of disposition
-
Pediatric asthma care demands better proper inhaler use
-
Physician burnout is not a failure of resilience
-
How a clinical trial changed the way I see Mother’s Day
-
What no one tells you about fertility, from a doctor
-
Why bipolar II is not just a milder version of bipolar I
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
